Answers are grounded in this paper and cite their sources.
Background: Sepsis complications in the elderly arise from factors such as comorbidities and malnutrition.The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in mitigating these complications remains underexplored.Methods: We analyzed 2008-2011 data for sepsis patients aged 65+.Cases had sepsis complications; controls did not.Patients were matched 1:1 on several factors.The association between statin use and complications was examined using multivariate conditional logistic regression, adjusting for geriatric syndromes.Results: Of participants (average age 78.5; 55.7% female), 40% used statins.Statin intake before hospitalization was less common in cases (25.2% vs. 54.8%;p < 0.001).Regression showed an inverse association between statin use and sepsis complications, consistent even after geriatric syndrome adjustments (odds ratios 0.26; 95% confidence intervals 0.12-0.55,p < 0.001).Conclusion: Statins appear protective against sepsis complications in the elderly.However, due to study design and existing ambiguities, results should be interpreted cautiously.Further research is advocated.
No takes yet. Share an insight, caveat, or question.
Barrientos-Ávalos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: